Literature DB >> 16791394

Development of new therapies, including regeneration of the kidney, for chronic kidney diseases.

Matsuhiko Hayashi1.   

Abstract

The increasing number of patients on chronic hemodialysis is a great problem in the field of nephrology in Japan and Western countries. Current therapies for chronic kidney diseases (CKDs) can retard the progression of renal failure, but cannot completely stop their progression to endstage renal failure (ESRD). Many researchers are now studying new therapeutic targets for CKDs, by various methods. Furthermore, because organ donation for kidney transplantation is very limited in Japan, research on kidney regeneration is an important issue for the therapy of ESRD. To regenerate the kidney, stem cells and growth factors for the kidney are being extensively studied, although the clinical application of the results of these studies has not yet taken place.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16791394     DOI: 10.1007/s10157-006-0418-7

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.617


  19 in total

1.  The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells.

Authors:  Toshiyuki Imasawa; Yasunori Utsunomiya; Tetsuya Kawamura; Y U Zhong; Ryuji Nagasawa; Masaru Okabe; Naoki Maruyama; Tatsuo Hosoya; Tsuneya Ohno
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

2.  Cloning and characterization of a novel gene promoting ureteric bud branching in the metanephros.

Authors:  Takashi Araki; Matsuhiko Hayashi; Takao Saruta
Journal:  Kidney Int       Date:  2003-12       Impact factor: 10.612

Review 3.  Pathophysiology of disease progression in proteinuric nephropathies.

Authors:  Norberto Perico; Igor Codreanu; Arrigo Schieppati; Giuseppe Remuzzi
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

4.  Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues.

Authors:  Takashi Yokoo; Toya Ohashi; Jin Song Shen; Ken Sakurai; Yoichi Miyazaki; Yasunori Utsunomiya; Masanori Takahashi; Yoshio Terada; Yoshikatsu Eto; Tetsuya Kawamura; Noriko Osumi; Tatsuo Hosoya
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

5.  Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells.

Authors:  Takahiko Kobayashi; Hiroyuki Tanaka; Hitoshi Kuwana; Seiji Inoshita; Hirobumi Teraoka; Sei Sasaki; Yoshio Terada
Journal:  Biochem Biophys Res Commun       Date:  2005-10-21       Impact factor: 3.575

6.  Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis.

Authors:  Masateru Yamada; Susumu Katsuma; Tetsuya Adachi; Akira Hirasawa; Satoshi Shiojima; Tadashi Kadowaki; Yasushi Okuno; Taka-aki Koshimizu; Shigeo Fujii; Yumiko Sekiya; Yohei Miyamoto; Mitsutaka Tamura; Wako Yumura; Hiroshi Nihei; Makio Kobayashi; Gozoh Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

7.  Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.

Authors:  Atsuhiro Ichihara; Matsuhiko Hayashi; Yuki Kaneshiro; Fumiaki Suzuki; Tsutomu Nakagawa; Yuko Tada; Yukako Koura; Akira Nishiyama; Hirokazu Okada; M Nasir Uddin; A H M Nurun Nabi; Yuichi Ishida; Tadashi Inagami; Takao Saruta
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Human and porcine early kidney precursors as a new source for transplantation.

Authors:  Benjamin Dekel; Tatyana Burakova; Fabian D Arditti; Shlomit Reich-Zeliger; Oren Milstein; Sarit Aviel-Ronen; Gideon Rechavi; Nir Friedman; Naftali Kaminski; Justen H Passwell; Yair Reisner
Journal:  Nat Med       Date:  2002-12-23       Impact factor: 53.440

9.  Bone marrow stem cells contribute to repair of the ischemically injured renal tubule.

Authors:  Sujata Kale; Anil Karihaloo; Paul R Clark; Michael Kashgarian; Diane S Krause; Lloyd G Cantley
Journal:  J Clin Invest       Date:  2003-06-16       Impact factor: 14.808

10.  Microarray analysis of a reversible model and an irreversible model of anti-Thy-1 nephritis.

Authors:  M Tsuji; T Monkawa; J Yoshino; M Asai; S Fukuda; H Kawachi; F Shimizu; M Hayashi; T Saruta
Journal:  Kidney Int       Date:  2006-03       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.